Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Whither Sanofi R&D? Another Setback For An Oncology Drug
Whither Sanofi R&D? Another Setback For An Oncology Drug
Whither Sanofi R&D? Another Setback For An Oncology Drug
Submitted by
admin
on November 18, 2013 - 10:05am
Source:
Pharmalot
News Tags:
Sanofi
R&D
fedratinib
myelofibrosis
Headline:
Whither Sanofi R&D? Another Setback For An Oncology Drug
Do Not Allow Advertisers to Use My Personal information
